Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience
NCT ID: NCT03240510
Last Updated: 2017-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2014-01-01
2018-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Goal of the retrospective part: to gather clinicopathologic data and follow-up outcomes of male breast cancer patients diagnosed and/or treated at Salah Azaïz Cancer Institute from 2004 to 2013.
Goal of the prospective part: to create a registry of male patients with breast cancer for a period of 48 months (from 2014 to 2017).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Male Breast Cancer: Understanding the Biology for Improved Patient Care
NCT01101425
Demographic , Clinicopathological Characteristics and Survival of Breast Cancer
NCT04316247
Concordance of the Biology of Primary Breast Carcinoma and the Biology of Recurrence , Retrospective Study.
NCT07275203
The Treatment Situation of Chinese County Population With Breast Cancer
NCT05544123
Prospective & Retrospective Data Collection of Breast Cancer Cases From 2000 to Present
NCT00534755
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Salah Azaïz Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Syrine Abdeljaoued
PhD in Oncology, Study Chair
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Syrine Abdeljaoued, PhD
Role: STUDY_CHAIR
Salah Azaïz Cancer Institute
Ilhem Bettaieb, Dr
Role: PRINCIPAL_INVESTIGATOR
Salah Azaïz Cancer Institute
Amor Gamoudi, Pr
Role: PRINCIPAL_INVESTIGATOR
Salah Azaïz Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Salah Azaïz Cancer Institute
Tunis, , Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SalahSCI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.